Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 ...

Avak Kahvejian, PhD, a general partner with biotech incubator Flagship Pioneering, discusses how AI is rearchitecting methods ...

Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson’s Disease and Movement Disorders® 2025·     Details of the Phase 3 ...

Ab Science (($ABSCF)) announced an update on their ongoing clinical study. Ab Science is spearheading a pivotal Phase 3 clinical trial titled ‘A ...

SOL-1 superiority trial continues to demonstrate outstanding patient retention and protocol adherence, with no new or unexpected safety signals ...

SpaceX is ramping up testing of its second launch pad at Starbase, conducting multiple checkouts of the water deluge system ...

Press Release Nicox's NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Additional pre-planned analysis of the NCX 470 Denali trial ...

SKY-0515 was developed through Skyhawk's proprietary integrated platform, SKYSTAR ®, and is the first Skyhawk drug in clinical trials.

AusBiotech welcomes the Albanese Government's announcement of a $13.6 million investment to progress national health and medical research reforms and ...

At Snapdragon Summit, we sat down with Qualcomm’s head of compute to unpack the company’s most ambitious PC processors yet.

Detailed price information for Satellos Bioscience Inc (MSCL-T) from The Globe and Mail including charting and trades.